Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Redd&Whyte Appoints New Director of Business Development

Published: Thursday, August 23, 2012
Last Updated: Wednesday, August 22, 2012
Bookmark and Share
Appointment of Rob Harkness as part of new growth strategy.

RobHarkness.gifRedd&Whyte has appointed Rob Harkness, PhD, to Director of Business Development in order to expand Redd&Whyte’s customer base across Europe and north America.

The appointment is one of a series of new hires, amid strategic restructuring within Redd&Whyte.

Rob Harkness brings specialist technical understanding of software and robotics, in addition to an impressive track record in business development.

He joins Redd&Whyte from Process Analysis & Automation, Ltd (PAA), where he worked for 13 years, initially as a software programmer and project manager, before progressing to leading Business Development in 2010.

His PhD (University of Surrey) focused on novel scheduling software for biochemical assays.

Rob made a significant contribution to PAA’s success in becoming a major provider of laboratory automated solutions, and will now lead Redd&Whyte’s global Business Development team.

“This is a crucial time for our company,” said Roger Poole, Managing Director at Redd&Whyte. “We have been making significant changes on a number of levels over the past few months, and Rob’s appointment forms an important part of our new business strategy.”

“It also demonstrates our continued commitment to developing enabling technology for our customers, through our approach of open innovation,” Roger said.

Roger continued, “Our products, including the award-winning Preddator microplate dispenser, are all developed through close collaboration with our customers, to help solve their liquid handling challenges and overcome perceived barriers to research.”

Redd&Whyte is involved in developing a range of novel robotic instruments with the fluid handling capabilities that laboratory scientists need to actually achieve their research visions.

The company’s specialist areas include nano dispensing, high throughput screening and point of care (PoC) testing.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Inroads Against Leukemia
Potential for halting disease in molecule isolated from sea sponges.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
A Fundamental Protection Mechanism Against Formalin In Mammals is Revealed
Formaldehyde, or formalin, is well known to all of us as a common chemical used in many industrial processes and also as a preservative, remarkably we also produce formaldehyde in our bodies.
Drug Used To Treat HIV Linked to Lower Bone Mass in Newborns
NIH study finds mothers’ use of tenofovir tied to lower bone mineral content in babies.
Bone Risks Linked to Genetic Variants
A large-scale genomic study uncovered novel genetic variants and led researchers to an unexpected gene that affects bone density and fracture risk.
Combo of 3 Antibiotics Can Kill Deadly Staph Infections
Three antibiotics that, individually, are not effective against a drug-resistant staph infection can kill the deadly pathogen when combined as a trio, according to new research.
Microbe Artwork Shows The Limits Of Antibiotics
An Oxford University research fellow has been creating art using bacteria found in the human gut and harvested from faecal samples.
Urine Excretion From Stem Cell-Derived Kidneys
Researchers report a strategy for enabling urine excretion from kidneys grown from stem cells.
Low Dose Beta-Blockers As Effective As High Dose After a Heart Attack?
Heart attack patients live as long – or even longer – on one-quarter the suggested dose.
Antidepressants Plus Blood-Thinners Slow Down Brain Cancer
EPFL scientists have found that combining antidepressants with anticoagulants slows down brain tumors (gliomas) in mice.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos